Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
- Conditions
- Postoperative ComplicationsAlcohol Use Disorder
- Registration Number
- NCT06864819
- Lead Sponsor
- University Hospitals Cleveland Medical Center
- Brief Summary
This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patients who are planned to stay in the hospital for three or more days after surgery regardless if they drink alcohol. Specifically, it will look at if PEth levels are connected to problems that might come up during and after surgery, like confusion, lung or heart issues, needing blood transfusions, infections, unexpected intensive care unit (ICU) stays, and longer hospital stays. While there are reports of moderate alcohol consumption being good for the heart, there are other data that alcohol consumption can be harmful. Since there's not much information on how drinking alcohol affects health outcomes during and after surgery, especially for patients who are planned to be admitted to the hospital ward or ICU after surgery, this study will hopefully see if PEth levels before surgery can predict how patients do after the surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 170
-
- Age range: 21-79
-
- Patients undergoing elective surgery at UHCMC with planned ICU admission
-
- Patients undergoing elective surgery at UHCMC with expected in-hospital admission for three or more days
-
- Patients undergoing same day outpatient surgeries or expected to be admitted less than three days post-operatively
-
- Subjects who have received a blood transfusion within the past month before surgery
-
- Pregnant subjects
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phosphatidylethanol level as measured by blood draw. Baseline Length of ICU stay measured in days Up to 7 days Length of hospital stay measured in days Up to 2 weeks Number of perioperative complications as measured by medical record review. Up to six months Perioperative complications including but not limited to delirium, pulmonary complications, cardiovascular complications, need for transfusion including amount transfused, post-operative infections, unexpected admission to the intensive care unit (ICU) and increased length of stay
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Hospital
🇺🇸Cleveland, Ohio, United States